|
1
|
Peng J, Liu HZ, Zhong J, Deng ZF, Tie CR,
Rao Q, Xu W, You T, Li J, Cai CB, et al: MicroRNA-187 is an
independent prognostic factor in lung cancer and promotes lung
cancer cell invasion via targeting of PTRF. Oncol Rep.
36:2609–2618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gkolfinopoulos S and Mountzios G: Beyond
EGFR and ALK: targeting rare mutations in advanced non-small cell
lung cancer. Ann Transl Med. 6:1422018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gallant JN and Lovly CM: Established,
emerging and elusive molecular targets in the treatment of lung
cancer. J Pathol. 244:565–577. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen C, Zhao Z, Liu Y and Mu D:
MicroRNA-99a is downregulated and promotes proliferation, migration
and invasion in non-small cell lung cancer A549 and H1299 cells.
Oncol Lett. 9:1128–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu HZ, Du CX, Luo J, Qiu XP, Li ZH, Lou
QY, Yin Z and Zheng F: A novel mutation in nuclear prelamin a
recognition factor-like causes diffuse pulmonary arteriovenous
malformations. Oncotarget. 8:2708–2718. 2017.PubMed/NCBI
|
|
6
|
Mishra N, Timilsina U, Ghimire D, Dubey RC
and Gaur R: Downregulation of cytochrome c oxidase subunit 7A1
expression is important in enhancing cell proliferation in
adenocarcinoma cells. Biochem Biophys Res Commun. 482:713–719.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gridley T: Notch signaling in the
vasculature. Curr Top Dev Biol. 92:277–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Phng LK and Gerhardt H: Angiogenesis: A
team effort coordinated by notch. Dev Cell. 16:196–208. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gale NW, Dominguez MG, Noguera I, Pan L,
Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J, et
al: Haploinsufficiency of delta-like 4 ligand results in embryonic
lethality due to major defects in arterial and vascular
development. Proc Natl Acad Sci USA. 101:15949–15954. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siekmann AF and Lawson ND: Notch
signalling limits angiogenic cell behaviour in developing zebrafish
arteries. Nature. 445:781–784. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Patel NS, Li JL, Generali D, Poulsom R,
Cranston DW and Harris AL: Up-regulation of Delta-like 4 ligand in
human tumor vasculature and the role of basal expression in
endothelial cell function. Cancer Res. 65:8690–8697. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Patel NS, Dobbie MS, Rochester M, Steers
G, Poulsom R, Le Monnier K, Cranston DW, Li JL and Harris AL:
Upregulation of endothelial Delta-like 4 expressioncorrelates with
vessel maturation in bladder cancer. Clin Cancer Res. 12:4836–4844.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jubb AM, Soilleux EJ, Turley H, Steers G,
Parker A, Low I, Blades J, Li JL, Allen P, Leek R, et al:
Expression of vascular Notch ligand Delta-like 4 and inflammatory
markers in breast cancer. Am J Pathol. 176:2019–2028. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noguera-Troise I, Daly C, Papadopoulos NJ,
Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD and Thurston
G: Blockade of Dll4 inhibits tumour growth by promoting
non-productive angiogenesis. Nature. 444:1032–1037. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ridgway J, Zhang G, Wu Y, Stawicki S,
Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I,
et al: Inhibition of Dll4 signalling inhibits tumour growth by
deregulating angiogenesis. Nature. 444:1083–1087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li JL, Sainson RCA, Shi W, Leek R,
Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E,
Hainfellner JA and Harris AL: Delta-like 4 Notch ligand regulates
tumor angiogenesis, improves tumor vascular function, and promotes
tumor growth in vivo. Cancer Res. 67:11244–11253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
International Union against Cancer: TNM
Classification of Malignant Tumours. Sobin LH, Gospodarowicz MK and
Wittekind C: 7th edition. Wiley-Blackwell; Hoboken, NJ: 2009
|
|
18
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger K, Yatabe Y, Powell CA, Beer D, Riely G,
Garg K, et al: International association for the study of lung
cancer/american thoracic society/european respiratory society:
International multidisciplinary classification of lung
adenocarcinoma: Executive summary. Proc Am Thorac Soc. 8:381–385.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kononen J, Bubendorf L, Kallioniemi A,
Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G
and Kallioniemi OP: Tissue microarrays for high-throughput
molecular profiling of tumor specimens. Nat Med. 4:844–847. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhong Z, Xia Y, Wang P, Liu B and Chen Y:
Low expression of microRNA-30c promotes invasion by inducing
epithelial mesenchymal transition in non-small cell lung cancer.
Mol Med Rep. 10:2575–2579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu G, Herazo-Maya JD, Nukui T, Romkes M,
Parwani A, Juan-Guardela BM, Robertson J, Gauldie J, Siegfried JM,
Kaminski N, et al: Matrix metalloproteinase-19 promotes metastatic
behavior in vitro and is associated with increased mortality in
non-small cell lung cancer. Am J Respir Crit Care Med. 190:780–790.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong K, Chen K, Han L and Li B:
MicroRNA-30b/c inhibits non-small cell lung cancer cell
proliferation by targeting Rab18. BMC Cancer. 14:7032014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Biyashev D, Veliceasa D, Topczewski J,
Topczewska JM, Mizgirev I, Vinokour E, Reddi AL, Licht JD, Revskoy
SY and Volpert OV: miR-27b controls venous specification and tip
cell fate. Blood. 119:2679–2687. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bridge G, Monteiro R, Henderson S, Emuss
V, Lagos D, Georgopoulou D, Patient R and Boshoff C: The
microRNA-30 family targets DLL4 to modulate endothelial cell
behavior during angiogenesis. Blood. 120:5063–5072. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scehnet JS, Jiang W, Kumar SR, Krasnoperov
V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A,
et al: Inhibition of Dll4-mediated signaling induces proliferation
of immature vessels and results in poor tissue perfusion. Blood.
109:4753–4760. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Haller BK, Bråve A, Wallgard E, Roswall P,
Sunkari VG, Mattson U, Hallengärd D, Catrina SB, Hellström M and
Pietras K: Therapeutic efficacy of a DNA vaccine targeting the
endothelial tip cell antigen delta-like ligand 4 in mammary
carcinoma. Oncogene. 29:4276–4286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kalén M, Heikura T, Karvinen H, Nitzsche
A, Weber H, Esser N, Ylä-Herttuala S and Hellström M:
Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood
vessel growth and vascular leakage but disrupts neovascular
perfusion. PLoS One. 6:e187092011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Segarra M, Williams CK, de la Luz SM,
Bernardo M, McCormick PJ, Maric D, Regino C, Choyke P and Tosato G:
Dll4 activation of Notch signaling reduces tumor vascularity and
inhibits tumor growth. Blood. 112:1904–1911. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hellström M, Phng LK, Hofmann JJ, Wallgard
E, Coultas L, Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N,
et al: Dll4 signalling through Notch1 regulates formation of tip
cells during angiogenesis. Nature. 445:776–780. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leslie JD, Ariza-McNaughton L, Bermange
AL, McAdow R, Johnson SL and Lewis J: Endothelial signalling by the
Notch ligand Delta-like 4 restricts angiogenesis. Development.
134:839–844. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Trindade A, Djokovic D, Gigante J,
Mendonça L and Duarte A: Endothelial Dll4 overexpression reduces
vascular response and inhibits tumor growth and metastasization in
vivo. BMC Cancer. 17:1892017. View Article : Google Scholar : PubMed/NCBI
|
